The Dow Chemical Company (NYSE:DOW) stock is currently pricing at roughly $62.52. Our analysis shows that the stock is widely covered by equity research firms, and target prices are revealing. From a summary standpoint, we track the median one-year price target among 17 analysts covering the company at $72.00. That suggests shares of the stock may have another 13 percent to the upside left to run. Of those analysts we surveyed, the highest price target on recordsits at $85.00, which would imply another 64 percent in upside potential. If we look for a little more qualitative data on the range of expectations, we find in analyst notes that the stock has 9 “Buy” ratings in place. At the same time, 7 rate the stock a “strong buy”, suggesting more conviction in the story. As for the doubters, 5 equity research analyst firms call this stock a “Hold” and 0 consider it bad enough to warrant a “Sell” rating.
Analysts at Jefferies took a look at DOW shares in a research note released on Mar 06, 2017, and issued a Buy rating to this company. UBS analysts provided their own take on company recently as well. In a research note published on Oct 10, 2016,the house assigned a Buy rating to this stock. According to a piece that hit the wires on Oct 03, 2016, researchers at Citigroup reconsidered their prior rating on the stock, and upped it from Neutral Perform to Buy.
The Dow Chemical Company (DOW) Cap Table Analysis
Breaking down the capitalization table is our next goal. From a bird’s eye view, Executives hold 0.50 percent of the stock.
If we take a more granular look, Heinz Haller is one of the largest owners in company capital stock among insiders. According to U.S. Securities and Exchange Commission (SEC) filings, this investor owns 741,785 shares, representing a total current market value of roughly $46376398.2. Gregory M. Freiwald is another major player among company insiders, currently holding 542,766 shares as of less than 0.1%, carrying a current market value of $33933730.32. Charles J. Kalil is currently ranked as the number three insider in terms of representation on the cap table for the stock, holding 448,002 shares, valued at around $28009085.04 as of recent close.
We noted a few insider transactions for the stock recently as well.
In a transaction on 2016-11-01, the company’s Director BELL JAMES A sold 1,336 company shares for 71880. That means, once accounting for this transaction, the Director is left with a stake of 32,906 shares, carrying a current total market value of $2057283. In addition, by means of a transaction dated 2015-11-03, Corporate VP & Treasurer RUIZ FERNANDO sold 20,000 shares worth $1047000. After that transaction, this investor is left with a total holding of 160,821 shares, representing a total investment value of $10054528.92. We also noted a 2015-02-11 transaction in which DOW Director SHAW RUTH G purchased 4,154 shares at a stock price of $48.19, carrying a total value of $200180, after which, this insider’s investment stands at 32,424 shares, with an overall financial value of $2027148.
The Dow Chemical Company (NYSE:DOW) Earnings View
In the company’s last quarter, DOW EPS moved to $1.04 from $0.99 compared sequentially with the prior quarter. Revenues for the company came in at $13.23BM. This stacks up against $13.02BM, on a sequential basis.
How does this compare with bottom and top-line expectations? Well, according to what we could find, analysts had been looking for the company to post net income of about $0.99 per share on $12.46BM in revenue. That sets up an interesting next quarter report card. We would note that analysts seem to be projecting earnings, on average, for this quarter in the range of $0.95 to $1.16. On a year-over-year basis, that compares with an EPS comp of $0.95.